Osteopontin directly modulates cytokine expression of primary microglia and increases their survival

Journal of Neuroimmunology

Volumn 299, Issue , 2016, Pages 130-138

  Rabenstein, Monika ^a   Vay, Sabine Ulrike ^a   Flitsch, Lea Jessica ^a   Fink, Gereon Rudolf ^a,b   Schroeter, Michael ^a,b   Rueger, Maria Adele ^a,b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

Focal cerebral ischemia; Neural stem cells; Neuroinflammation; Neuroprotection; Regeneration

Indexed keywords

CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; OSTEOPONTIN; TUMOR NECROSIS FACTOR; SPP1 PROTEIN, RAT;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; GENE EXPRESSION; MICROGLIA; MICROGLIAL CELL CULTURE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECTS; GENETICS; METABOLISM; NEWBORN; PHYSIOLOGY;

ANIMALS; ANIMALS, NEWBORN; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; MICROGLIA; OSTEOPONTIN; RATS;

EID: 84987912357     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2016.09.009     Document Type: Article

References (50)

1. Aguzzi, A., Barres, B.A., Bennett, M.L., Microglia: scapegoat, saboteur, or something else?. Science 339 (2013), 156–161.
2. Ashkar, S., Weber, G.F., Panoutsakopoulou, V., Sanchirico, M.E., Jansson, M., Zawaideh, S., et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287 (2000), 860–864.
3. Brown, A., Osteopontin: a key link between immunity, inflammation and the central nervous system. Transl. Neurosci. 3 (2012), 288–293.
4. Butler, W.T., The nature and significance of osteopontin. Connect. Tissue Res. 23 (1989), 123–136.
5. Chabas, D., Baranzini, S.E., Mitchell, D., Bernard, C.C., Rittling, S.R., Denhardt, D.T., et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294 (2001), 1731–1735.
6. Cherry, J.D., Olschowka, J.A., O'Banion, M.K., Are “resting” microglia more “m2”?. Front. Immunol., 5, 2014, 594.
7. Cherry, J.D., Olschowka, J.A., O'Banion, M.K., Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J. Neuroinflammation, 11, 2014, 98.
8. Denhardt, D.T., Guo, X., Osteopontin: a protein with diverse functions. FASEB J. 7 (1993), 1475–1482.
9. Denhardt, D.T., Noda, M., O'Regan, A.W., Pavlin, D., Berman, J.S., Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J. Clin. Invest. 107 (2001), 1055–1061.
10. Doyle, K.P., Yang, T., Lessov, N.S., Ciesielski, T.M., Stevens, S.L., Simon, R.P., et al. Nasal administration of osteopontin peptide mimetics confers neuroprotection in stroke. J. Cereb. Blood Flow Metab. 28 (2008), 1235–1248.
11. Ekdahl, C.T., Microglial activation - tuning and pruning adult neurogenesis. Front. Pharmacol., 3, 2012, 41.
12. Ellison, J.A., Velier, J.J., Spera, P., Jonak, Z.L., Wang, X., Barone, F.C., et al. Osteopontin and its integrin receptor alpha(v)beta3 are upregulated during formation of the glial scar after focal stroke. Stroke 29 (1998), 1698–1706 discussion 707.
13. Franco, R., Fernández-Suárez, D., Alternatively activated microglia and macrophages in the central nervous system. Prog. Neurobiol. 131 (2015), 65–86.
14. Fumagalli, S., Perego, C., Pischiutta, F., Zanier, E.R., De Simoni, M.G., The ischemic environment drives microglia and macrophage function. Front. Neurol., 6, 2015, 81.
15. Gao, C., Guo, H., Mi, Z., Grusby, M.J., Kuo, P.C., Osteopontin induces ubiquitin-dependent degradation of STAT1 in RAW264.7 murine macrophages. J. Immunol. 178 (2007), 1870–1881.
16. Giachelli, C.M., Liaw, L., Murry, C.E., Schwartz, S.M., Almeida, M., Osteopontin expression in cardiovascular diseases. Ann. N. Y. Acad. Sci. 760 (1995), 109–126.
17. Giachelli, C.M., Lombardi, D., Johnson, R.J., Murry, C.E., Almeida, M., Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am. J. Pathol. 152 (1998), 353–358.
18. Gliem, M., Krammes, K., Liaw, L., van Rooijen, N., Hartung, H.P., Jander, S., Macrophage-derived osteopontin induces reactive astrocyte polarization and promotes re-establishment of the blood brain barrier after ischemic stroke. Glia 63 (2015), 2198–2207.
19. Guo, H., Cai, C.Q., Schroeder, R.A., Kuo, P.C., Osteopontin is a negative feedback regulator of nitric oxide synthesis in murine macrophages. J. Immunol. 166 (2001), 1079–1086.
20. Hedtjärn, M., Mallard, C., Hagberg, H., Inflammatory gene profiling in the developing mouse brain after hypoxia-ischemia. J. Cereb. Blood Flow Metab. 24 (2004), 1333–1351.
21. Hu, X., Li, P., Guo, Y., Wang, H., Leak, R.K., Chen, S., et al. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 43 (2012), 3063–3070.
22. Hur, E.M., Youssef, S., Haws, M.E., Zhang, S.Y., Sobel, R.A., Steinman, L., Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat. Immunol. 8 (2007), 74–83.
23. Hwang, S.M., Lopez, C.A., Heck, D.E., Gardner, C.R., Laskin, D.L., Laskin, J.D., et al. Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. J. Biol. Chem. 269 (1994), 711–715.
24. Jin, Y.C., Lee, H., Kim, S.W., Kim, I.D., Lee, H.K., Lee, Y., et al. Intranasal delivery of RGD motif-containing osteopontin icosamer confers neuroprotection in the postischemic brain via αvβ3 integrin binding. Mol. Neurobiol., 2015.
25. Kawamura, K., Iyonaga, K., Ichiyasu, H., Nagano, J., Suga, M., Sasaki, Y., Differentiation, maturation, and survival of dendritic cells by osteopontin regulation. Clin. Diagn. Lab. Immunol. 12 (2005), 206–212.
26. Koyama, Y., Kimura, Y., Yoshioka, Y., Wakamatsu, D., Kozaki, R., Hashimoto, H., et al. Serum-deprivation induces cell death of rat cultured microglia accompanied with expression of Bax protein. Jpn. J. Pharmacol. 83 (2000), 351–354.
27. Kreutzberg, G.W., Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19 (1996), 312–318.
28. Lee, J.L., Wang, M.J., Sudhir, P.R., Chen, G.D., Chi, C.W., Chen, J.Y., Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells. Cancer Res. 67 (2007), 2089–2097.
29. Lin, Y.H., Yang-Yen, H.F., The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway. J. Biol. Chem. 276 (2001), 46024–46030.
30. Lin, Y.H., Huang, C.J., Chao, J.R., Chen, S.T., Lee, S.F., Yen, J.J., et al. Coupling of osteopontin and its cell surface receptor CD44 to the cell survival response elicited by interleukin-3 or granulocyte-macrophage colony-stimulating factor. Mol. Cell. Biol. 20 (2000), 2734–2742.
31. Lund, S.A., Wilson, C.L., Raines, E.W., Tang, J., Giachelli, C.M., Scatena, M., Osteopontin mediates macrophage chemotaxis via α4 and α9 integrins and survival via the α4 integrin. J. Cell. Biochem. 114 (2013), 1194–1202.
32. Luo, X., Ruhland, M.K., Pazolli, E., Lind, A.C., Stewart, S.A., Osteopontin stimulates preneoplastic cellular proliferation through activation of the MAPK pathway. Mol. Cancer Res. 9 (2011), 1018–1029.
33. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., Locati, M., The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25 (2004), 677–686.
34. Meller, R., Stevens, S.L., Minami, M., Cameron, J.A., King, S., Rosenzweig, H., et al. Neuroprotection by osteopontin in stroke. J. Cereb. Blood Flow Metab. 25 (2005), 217–225.
35. Patouraux, S., Rousseau, D., Rubio, A., Bonnafous, S., Lavallard, V.J., Lauron, J., et al. Osteopontin deficiency aggravates hepatic injury induced by ischemia-reperfusion in mice. Cell Death Dis., 5, 2014, e1208.
36. Pazolli, E., Luo, X., Brehm, S., Carbery, K., Chung, J.J., Prior, J.L., et al. Senescent stromal-derived osteopontin promotes preneoplastic cell growth. Cancer Res. 69 (2009), 1230–1239.
37. Rabenstein, M., Hucklenbroich, J., Willuweit, A., Ladwig, A., Fink, G.R., Schroeter, M., et al. Osteopontin mediates survival, proliferation and migration of neural stem cells through the chemokine receptor CXCR4. Stem Cell Res. Ther., 6, 2015, 99.
38. Ritzel, R.M., Patel, A.R., Grenier, J.M., Crapser, J., Verma, R., Jellison, E.R., et al. Functional differences between microglia and monocytes after ischemic stroke. J. Neuroinflammation, 12, 2015, 106.
39. Rollo, E.E., Laskin, D.L., Denhardt, D.T., Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages. J. Leukoc. Biol. 60 (1996), 397–404.
40. Schroeter, M., Jander, S., Witte, O.W., Stoll, G., Local immune responses in the rat cerebral cortex after middle cerebral artery occlusion. J. Neuroimmunol. 55 (1994), 195–203.
41. Schroeter, M., Saleh, A., Wiedermann, D., Hoehn, M., Jander, S., Histochemical detection of ultrasmall superparamagnetic iron oxide (USPIO) contrast medium uptake in experimental brain ischemia. Magn. Reson. Med. 52 (2004), 403–406.
42. Schroeter, M., Zickler, P., Denhardt, D.T., Hartung, H.P., Jander, S., Increased thalamic neurodegeneration following ischaemic cortical stroke in osteopontin-deficient mice. Brain 129 (2006), 1426–1437.
43. Shin, Y.J., Kim, H.L., Choi, J.S., Choi, J.Y., Cha, J.H., Lee, M.Y., Osteopontin: correlation with phagocytosis by brain macrophages in a rat model of stroke. Glia 59 (2011), 413–423.
44. Singh, K., DeVouge, M.W., Mukherjee, B.B., Physiological properties and differential glycosylation of phosphorylated and nonphosphorylated forms of osteopontin secreted by normal rat kidney cells. J. Biol. Chem. 265 (1990), 18696–18701.
45. Stoll, G., Jander, S., Schroeter, M., Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. Adv. Exp. Med. Biol. 513 (2002), 87–113.
46. Tambuyzer, B.R., Casteleyn, C., Vergauwen, H., Van Cruchten, S., Van Ginneken, C., Osteopontin alters the functional profile of porcine microglia in vitro. Cell Biol. Int. 36 (2012), 1233–1238.
47. Taylor, R.A., Sansing, L.H., Microglial responses after ischemic stroke and intracerebral hemorrhage. Clin. Dev. Immunol., 2013, 2013, 746068.
48. Topkoru, B.C., Altay, O., Duris, K., Krafft, P.R., Yan, J., Zhang, J.H., Nasal administration of recombinant osteopontin attenuates early brain injury after subarachnoid hemorrhage. Stroke 44 (2013), 3189–3194.
49. Wang, K.X., Denhardt, D.T., Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev. 19 (2008), 333–345.
50. Wang, X., Louden, C., Ohlstein, E.H., Stadel, J.M., Gu, J.L., Yue, T.L., Osteopontin expression in platelet-derived growth factor-stimulated vascular smooth muscle cells and carotid artery after balloon angioplasty. Arterioscler. Thromb. Vasc. Biol. 16 (1996), 1365–1372.